Showing results (2201-2210 of 9,152) with videos related to
Sort By:
Pageof 916
Cancer Medicine|July 1, 2023
Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissuesAnkita Chatterjee, Amrita Chaudhary, Arnab Ghosh, et al.Cancer Medicine|June 12, 2023
Comparison of eight modern preoperative scoring systems for survival prediction in patients with extremity metastasisTse-Ying Lee, Yu-An Chen, Olivier Q Groot, et al.Cancer Medicine|June 12, 2023
Genetic predisposition to metabolically unfavourable adiposity and prostate cancer risk: A Mendelian randomization analysisAurora Perez-Cornago, Karl Smith-Byrne, Emma Hazelwood, et al.Cancer Medicine|June 12, 2023
The role of extracellular vesicles in the development of nasopharyngeal carcinoma and potential clinical applicationsTiansong Liang, Linhui Chen, Xiaojing Liu, et al.Cancer Medicine|June 17, 2023
Effects of a lymphedema prevention program based on the theory of knowledge-attitude-practice on postoperative breast cancer patients: A randomized clinical trialBohui Shi, Zihan Lin, Xiaowei Shi, et al.Cancer Medicine|June 17, 2023
Enrollee characteristics and receipt of colorectal cancer testing in Pennsylvania after adoption of the Affordable Care Act Medicaid expansionKirsten Y Eom, Scott D Rothenberger, Marian P Jarlenski, et al.Cancer Medicine|June 17, 2023
Clinical and metabolomic characterization of Brivanib-Induced hypertension in metastatic colorectal cancerJodi I Rattner, Karen A Kopciuk, Hans J Vogel, et al.Cancer Medicine|June 19, 2023
Phase I study of cisplatin and nanoparticle albumin-bound-paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinomaHui Jiang, Qiaoqiao Li, Baoqing Chen, et al.Cancer Medicine|June 19, 2023
A Bayesian network meta-analysis of ALK inhibitor treatments in patients with ALK-positive non-small cell lung cancerBei Zheng, Hong Jiang, Wenjuan Yang, et al.Cancer Medicine|June 22, 2023
KCND2: A prognostic biomarker and regulator of immune function in gastric cancerHongying Zhou, Dan Su, Yun Chen, et al.Pageof 916